Kevin Charles Gorman, Director: Neurocrine Biosciences NBIX Planned sale · Filed 05/19

Trade details

Type: Planned sale notice
Stock: Neurocrine Biosciences NBIX
Person: Kevin Charles GormanDirector
Planned sale date: 26/05/19
Filed: 26/05/19

0.2% of shares outstanding to be sold

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 04/19~06/18

Kevin Charles Gorman's recent trades

Kevin Charles GormanDirector
Sell10b5-1 planXencor
Sell10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/17
Traded 06/15
Kevin Charles GormanDirector
Planned sale10b5-1 planXencor
Planned sale10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/15
Traded 06/15
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$37.8M
245,088 sh
$37.8M
Filed 05/21
Traded 05/19
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$13.4M
106,322 sh
$13.4M
Filed 25/08/11
Traded 25/08/07
Kevin Charles GormanDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$13.7M
106,322 sh
$13.7M
Filed 25/08/07
Traded 25/08/07